Keyphrases
Pharmacokinetics
100%
Obese Men
100%
Morbid Obesity
100%
Piperacillin-tazobactam
100%
Serum Concentration
60%
Steady State
40%
Dosing Scheme
40%
Steady-state Concentration
40%
Blood Samples
20%
Dose Rate
20%
Pseudomonas Aeruginosa (P. aeruginosa)
20%
Body Mass Index
20%
Published Data
20%
Confidence Interval
20%
Pharmacokinetic Changes
20%
Population Pharmacokinetics
20%
Area under the Curve
20%
Obese Patients
20%
Continuous Infusion
20%
Pharmacokinetic Parameters
20%
Serious Infection
20%
Optimal Dosing
20%
Group A Streptococcus
20%
Volume of Distribution
20%
Absolute Value
20%
Constant Volume
20%
Piperacillin
20%
Group B Streptococcus
20%
Overall Concentrations
20%
Elimination Rate
20%
Minimum Inhibitory Concentration
20%
Time Profile
20%
Wound Culture
20%
Peripheral Venous Catheter
20%
Recurrent Cellulitis
20%
Clearance Zone
20%
Pharmacology, Toxicology and Pharmaceutical Science
Piperacillin Plus Tazobactam
100%
Pharmacokinetics
100%
Pharmacokinetic Parameter
20%
Minimum Inhibitory Concentration
20%
Elimination Rate Constant
20%
Infectious Agent
20%
Infection
20%
Pseudomonas aeruginosa
20%
Wound
20%
Streptococcus Group A
20%
Cellulitis
20%
Volume of Distribution
20%
Piperacillin
20%